Last updated: April 7, 2026

Terms of Use

1. Acceptance of Terms

Welcome to The 483 (the483.com). These Terms of Use (“Terms”) govern your access to and use of the website, content, newsletter, and any related services (collectively, the “Service”) operated by The 483 (“we,” “us,” or “our”). By accessing or using the Service, you agree to be bound by these Terms. If you do not agree, you must not use the Service.

These Terms apply to all visitors, readers, newsletter subscribers, and other users of the Service. If you are using the Service on behalf of an organization, you represent that you have authority to bind that organization to these Terms.

2. About The 483

The 483 is an independent publication covering compliance, enforcement, and corporate news in regulated industries — including FDA enforcement actions, SEC enforcement, biotech and pharmaceutical mergers and acquisitions, lawsuits, and broader regulatory developments. The Service is operated by an individual publisher based in the United States.

What we are: An independent news publication focused on compliance and enforcement journalism. Our audience includes compliance officers, attorneys, biotech investors, and regulatory specialists.

What we are NOT:

  • We are NOT a law firm and do NOT provide legal advice or legal services.
  • We are NOT a registered investment advisor, broker-dealer, or financial planner, and do NOT provide investment advice or recommendations.
  • We are NOT licensed medical professionals and do NOT provide medical advice.
  • We are NOT regulators and do NOT speak for any government agency.
  • We are NOT auditors, accountants, or compliance consultants.

The Service is provided for general informational and journalistic purposes only.

3. Content & Editorial

The 483 publishes original news articles, summaries, and analysis. Our editorial process is AI-assisted journalism: we use large language models (including but not limited to Anthropic’s Claude) to help draft articles based on facts gathered from primary public sources, regulatory filings, press releases, and reputable third-party news outlets. All published articles are original works produced by The 483, not verbatim copies of source material.

While we strive for accuracy, completeness, and timeliness, we make no warranty that any article is free of errors, omissions, or misinterpretations. News develops rapidly, and information that is accurate at the time of publication may later become outdated, superseded, or incorrect. Readers are responsible for verifying any fact through primary sources before acting on it.

Where we link to a primary source (regulator filing, press release, or originating news outlet), readers are encouraged to consult that source directly. Our articles are starting points, not endpoints, for research.

4. Third-Party Content & Fair Use

The 483 reports on news that is, by its nature, drawn from publicly available information published by regulators, companies, and other news organizations. Our use of factual information from third-party sources is grounded in:

  • Public-domain factual reporting, including regulatory documents (FDA Form 483s, warning letters, SEC filings) which are works of the United States government and not subject to copyright.
  • Fair use under 17 U.S.C. § 107 and analogous doctrines in other jurisdictions, for purposes of news reporting, commentary, criticism, and education. Our use is transformative: we synthesize facts from multiple sources into original, short-form journalism, and we provide attribution and links to original sources.
  • Attribution: every article that draws from a third-party news source includes a link to that source.

Images displayed alongside articles may include OpenGraph preview images sourced from the originating publisher (used in a transformative, non-commercial news context with attribution), public-domain imagery, or Creative Commons-licensed material. If you are a rights holder and believe your work has been used improperly, please follow the DMCA procedure in Section 12.

5. User Conduct

You agree to use the Service only for lawful purposes and in a manner consistent with these Terms. You may:

  • Read and share links to our articles.
  • Quote short excerpts of our articles for commentary, education, or research, provided you include a clear attribution to The 483 and a link back to the original article.

You may NOT:

  • Scrape, crawl, harvest, or use any automated means to access or copy content from the Service, except for general-purpose search engine indexing in accordance with our robots.txt.
  • Republish, mirror, syndicate, or redistribute substantial portions of our content without prior written permission.
  • Use our content to train, fine-tune, or evaluate any machine learning model without prior written permission.
  • Misrepresent the source of our content or remove attribution.
  • Use the Service in any manner that could damage, disable, overburden, or impair it.
  • Attempt to gain unauthorized access to any portion of the Service or related systems.
  • Use the Service to transmit unlawful, defamatory, harassing, or infringing material.

6. Intellectual Property

All original text published on The 483 — including article copy, headlines, editorial commentary, and the visual design of the Service — is the intellectual property of The 483 and is protected by United States and international copyright laws. Underlying facts, regulatory documents, and government filings are not owned by us.

Permitted use of our original text: You may quote excerpts of up to 100 words from any article for non-commercial commentary, journalism, education, or research, provided you include attribution (“Source: The 483, the483.com”) and a link to the original article.

For any other use — including republication, syndication, or commercial reproduction — please contact hello@the483.com.

7. No Professional Advice

The content on The 483 is provided for informational and journalistic purposes only and does NOT constitute professional advice of any kind. Specifically, nothing on the Service should be construed as:

  • Legal advice. We are not your lawyers. No attorney-client relationship is created by reading the Service. Consult a licensed attorney in your jurisdiction before making any legal decision.
  • Investment advice. Nothing on the Service is an offer to buy or sell any security, a recommendation to invest, or a solicitation. We do not know your financial situation, risk tolerance, or objectives. Consult a registered investment advisor before making any investment decision. Past performance is not indicative of future results.
  • Medical advice. Nothing on the Service is medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before making any medical decision.
  • Regulatory guidance. We are not a regulator. Nothing on the Service should be relied upon as official guidance from the FDA, SEC, or any other agency. Always consult primary regulatory sources and qualified counsel.
  • Financial, tax, accounting, or compliance recommendation.

You acknowledge that you bear sole responsibility for any decision you make based on content from the Service.

8. Forward-Looking Statements

Articles on The 483 may contain forward-looking statements, predictions, projections, or speculation about companies, share prices, drug approvals, regulatory outcomes, enforcement actions, mergers, or other future events. These statements are inherently uncertain. Outcomes may differ materially from anything discussed on the Service. We make no warranty, express or implied, regarding the accuracy of any forward-looking statement, and we have no obligation to update such statements.

The Service contains links to third-party websites, including regulator websites, news outlets, and company press releases. These links are provided as a convenience and for attribution. We do not control, endorse, or accept responsibility for the content, privacy practices, or accuracy of any third-party site. Your use of any linked site is at your own risk and subject to that site’s terms.

10. Disclaimers & Limitation of Liability

THE SERVICE AND ALL CONTENT ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE 483 DISCLAIMS ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ACCURACY, COMPLETENESS, AND TIMELINESS.

WE DO NOT WARRANT THAT THE SERVICE WILL BE UNINTERRUPTED, ERROR-FREE, SECURE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. WE DO NOT WARRANT THAT ANY CONTENT IS ACCURATE, COMPLETE, RELIABLE, CURRENT, OR FREE OF ERROR.

TO THE MAXIMUM EXTENT PERMITTED BY LAW, IN NO EVENT SHALL THE 483, ITS OPERATOR, CONTRIBUTORS, OR AFFILIATES BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES — INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR INVESTMENT LOSSES — ARISING OUT OF OR RELATED TO YOUR USE OF, OR INABILITY TO USE, THE SERVICE OR ANY CONTENT, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

OUR AGGREGATE LIABILITY TO YOU FOR ANY AND ALL CLAIMS ARISING OUT OF OR RELATING TO THESE TERMS OR THE SERVICE SHALL NOT EXCEED ONE HUNDRED U.S. DOLLARS (USD $100).

Some jurisdictions do not allow the exclusion or limitation of certain warranties or damages. In such jurisdictions, our liability shall be limited to the greatest extent permitted by law.

11. Indemnification

You agree to indemnify, defend, and hold harmless The 483, its operator, contributors, and affiliates from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys’ fees) arising out of or related to: (a) your use or misuse of the Service; (b) your violation of these Terms; (c) your violation of any law or the rights of any third party; or (d) any content you submit or transmit through the Service.

12. DMCA Takedown Procedure

The 483 respects intellectual property rights and complies with the Digital Millennium Copyright Act (“DMCA”). If you believe that material on the Service infringes your copyright, please send a written notice to our Designated Agent containing the following:

  1. A physical or electronic signature of the copyright owner or a person authorized to act on their behalf.
  2. Identification of the copyrighted work claimed to have been infringed.
  3. Identification of the material that is claimed to be infringing, including its URL on the Service.
  4. Your contact information (name, address, phone, email).
  5. A statement that you have a good-faith belief that the use is not authorized by the copyright owner, its agent, or the law.
  6. A statement, under penalty of perjury, that the information in the notice is accurate and that you are authorized to act on behalf of the owner.

Designated DMCA Agent: The 483 Union Mills Way, Cary, NC, USA Email: hello@the483.com

We will respond to valid DMCA notices in accordance with the statute. We may also forward counter-notices and may, in appropriate circumstances, terminate the access of repeat infringers.

13. Corrections Policy

Accuracy matters. If you believe an article contains a factual error, please email hello@the483.com with the URL and a description of the issue. We review correction requests promptly. When we make a material correction, we update the article and add a note describing the change and the date. When possible, we also reference the primary source that supports the correction. Subjects of articles who believe they have been misrepresented may also use this process.

14. Governing Law & Jurisdiction

These Terms shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict-of-laws principles.

Binding arbitration. Any dispute, claim, or controversy arising out of or relating to these Terms or the Service shall be resolved by binding individual arbitration administered by the American Arbitration Association under its Consumer Arbitration Rules. Arbitration shall take place in Delaware, or remotely at the arbitrator’s discretion. Judgment on the award may be entered in any court of competent jurisdiction.

Class action waiver. YOU AND THE 483 AGREE THAT EACH MAY BRING CLAIMS AGAINST THE OTHER ONLY IN AN INDIVIDUAL CAPACITY AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS, CONSOLIDATED, OR REPRESENTATIVE PROCEEDING. The arbitrator may not consolidate more than one person’s claims and may not preside over any form of representative or class proceeding.

Opt-out. You may opt out of the arbitration agreement by sending written notice to hello@the483.com within 30 days of first accepting these Terms. Notice must include your name and a clear statement that you wish to opt out.

Severability. If any provision of these Terms is held to be invalid or unenforceable, the remaining provisions shall remain in full force and effect.

15. Changes to Terms

We may update these Terms from time to time. When we do, we will revise the “Last updated” date at the top. Material changes will be announced on the homepage and, where appropriate, via the newsletter. Your continued use of the Service after changes take effect constitutes your acceptance of the revised Terms.

16. Contact

Questions or notices regarding these Terms should be sent to:

The 483 Email: hello@the483.com DMCA: hello@the483.com Privacy: hello@the483.com